TMEM19 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the TMEM19 protein, a transmembrane protein encoded by the TMEM19 gene. Although the precise biological functions of TMEM19 are not fully elucidated, transmembrane proteins like TMEM19 are generally involved in various cellular processes such as signaling, transport, and maintaining cellular homeostasis. TMEM19 is thought to play a role in the organization of cellular membranes, possibly influencing the function of ion channels, receptors, or other membrane-associated proteins. Inhibitors of TMEM19 are developed to disrupt its normal activity, allowing researchers to study its role in cellular processes, particularly those related to membrane dynamics and signaling pathways.
The development of TMEM19 inhibitors involves a comprehensive approach that begins with a detailed analysis of the protein's structure and its functional domains. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional configuration of TMEM19. This structural information is essential for identifying key regions of the protein, such as the transmembrane domains and potential binding sites, where inhibitors could effectively target and modulate the protein's activity. Computational tools, including molecular docking and virtual screening, are then utilized to identify small molecules that can specifically bind to these sites with high affinity and selectivity. Once potential inhibitors are identified, they are synthesized and subjected to rigorous in vitro testing to evaluate their binding properties, specificity, and inhibitory potency. These compounds are further optimized through iterative cycles of chemical refinement to enhance their effectiveness and stability. The study of TMEM19 inhibitors not only provides insights into the specific functions of this transmembrane protein but also contributes to a broader understanding of the molecular mechanisms that regulate membrane dynamics, signaling, and cellular homeostasis within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $65.00 $162.00 $650.00 $2550.00 | 109 | |
Inhibits V-ATPase, which could disrupt intracellular pH and ion homeostasis, indirectly inhibiting TMEM19 activity that relies on pH-sensitive processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits V-ATPase, leading to altered endosomal/lysosomal acidification, potentially inhibiting TMEM19's role in trafficking or protein turnover. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), affecting calcium homeostasis and potentially disrupting TMEM19-related signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits tyrosine kinases, which could interfere with phosphorylation-dependent processes that TMEM19 might be involved in. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin-dependent endocytosis, potentially affecting TMEM19's role in membrane trafficking or signal transduction. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Disrupts actin polymerization, which could inhibit TMEM19's assumed role in maintaining cytoskeletal structure or related signaling pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Inhibits IP3 receptors and store-operated Ca2+ entry, potentially inhibiting TMEM19's function if it is involved in calcium signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibits myosin light chain kinase, potentially affecting cellular contractility and motility processes that TMEM19 might be associated with. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Inhibits protein kinase C, which could inhibit TMEM19's role in signal transduction pathways that involve protein kinase C activity. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Binds to actin monomers and prevents polymerization, which could inhibit TMEM19's role in cytoskeletal-dependent processes or vesicle trafficking. | ||||||